Development of pharmacogenomics education in China and the Unit-ed States
10.12092/j.issn.1009-2501.2024.09.015
- VernacularTitle:中美药物基因组学教育发展概况
- Author:
Quanlin WANG
1
;
Shusen SUN
;
Wei ZHANG
;
Dan CAO
;
Yisu JIN
Author Information
1. 中南大学湘雅医院临床药理研究所,长沙 410008,湖南
- Keywords:
pharmacogenomics;
course offering;
professional training;
clinical practice;
teaching de-sign
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2024;29(9):1076-1080
- CountryChina
- Language:Chinese
-
Abstract:
Pharmacogenomics(PGx)is a science based on functional genomics and molecular phar-macology,which has been rapidly developed and gradually applied to clinical practice in recent years.Therefore,China and the United States are committed to promoting the development of PGx education.This paper reviews PGx education in Chi-na and the United States,clarifies the significance of developing PGx education,and provides a de-tailed introduction to the current development sta-tus and challenges of PGx education in universities and clinical settings.Additionally,this paper makes some recommendations for developing PGx educa-tion and discusses future development trends in both countries.
